The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Laboratory Corp. of America Holdings  (LH) Trade Now »     Rate LH  -  Discuss LH  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Healthcare Facilities
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
100.0%
Top:
100.0%
Rate LH:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

LH: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

Create Your Own Diagnostics ETF Graphic_rating_buy LH
Mikerun
73%
 +25.84%
in 311 days
Create Your Own Diagnostics ETF
 
<> With HealthShares closing shop at year-end , including the former Diagnostics fund, investors who are interested in the space can create their own ETF comprised of companies from the ETF Innovators Preventive Medicine and Emerging Diagnostics Indexes. Below is a list of companies which have stocks listed for trading in the U.S. at over $1/share with a market cap of less than $10B, focusing on smaller companies which are more leveraged to diagnostics and represent possible takeover targets for larger players such as Roche (...
By  Mike Havrilla   (+1.04%  risk: conservative)  01/20/09 Comment


EXACT Sciences Rejects Sequenom's $41M Offer Graphic_rating_buy LH
Mikerun
73%
 -2.57%
in 8 days
(closed on 01/20/09)

Analyzing Sequenom's Offer for EXACT Sciences

<> Since I profiled EXACT Sciences (EXAS) in late December as part of the ETF Innovators Emerging Diagnostics Index , EXAS announced that its stool-based DNA [sDNA] screening test was added to the colorectal cancer screening options in 12 more states + Washington DC and the Company received an unsolicited, all-stock buyout offer from Sequenom (SQNM) after the market close on Friday, which is valued at $41M or $1.50 per share.

It has not been an easy ride for EXAS since I first wrote about the Company in October 2007, ...
By  Mike Havrilla   (+1.04%  risk: conservative)  01/12/09 Comment


Obama-Care Focused on Preventive Medicine Graphic_rating_buy LH
Mikerun
73%
 -1.85%
in 67 days
(closed on 01/12/09)

Obama-Care Focused on Preventive Medicine

<>

In addition to bullish outlooks for generic drugs and Health IT , President-Elect Obama's healthcare plan plans to focus on public health initiatives and mandated coverage of preventive services such as cancer screenings. The accompanying table presents statistics and the top five rated companies in the ETFI Preventive Medicine Index, including vaccine makers such as Emergent BioSolutions (EBS), diabetes care companies such as Novo Nordisk (NVO), diagnostic companies such as Sequenom (SQNM) and Myriad Geneti...
By  Mike Havrilla   (+1.04%  risk: conservative)  11/05/08 Comment


Laboratory Corporation of America (LH) Graphic_rating_buy LH
Robertfreedlandphoto
36%
 -7.11%
in 1014 days

...Again, I am going to try to be extremely brief with a post. Looking through the top % gainers on the NYSE today, I came across an old favorite of mine, Laboratory Corporation of America (LH) which closed at $80.00, up $5.56 or 7.47% on the day. I do not own any shares of this stock, nor do I own any options.

I first posted LH on Stock Picks Bob's Advice on June 20, 2003, as one of the earliest posts on this blog. At that time, the stock was trading at $30.68. With today's close at $80.00, this represents a gain of $49.32 or 160.8% since posting.

<>What drove the stock higher this morni...
By  Robert Freedland   (-5.56%  risk: aggressive)  02/16/07 Comment




From the Blogosphere

Genoptix Inc. (GXDX) Adding Physicians and Growing Revenue
Sl730001-3
49%


Genoptix Inc. (GXDX)Health Care has been a controversial topic for US investors.  Reforms to Medicare and regulations on private insurers will likely have an industry altering effect.  There have certainly been some land mines to dodge when investing in this sector, but profitable positions have also been available.  Take for instance Amedisys Inc. (AMED) which is up about 33% since the stock was recommended in here in April.  Amedisys is positioned to actually save Medicare costs and investors are bidding the stock higher in anticipation of the strength.

<form><input /><input /><input /><input /><input />...
By  Zachary Scheidt   (-6.77%  risk: moderate)  08/11/09 Comment


Monogram's Acquisition of LabCorp: What Does It Mean for the Molecular Diagnostics Industry?

By Grant Zeng, CFA

Early yesterday morning, Laboratory Corporation of America® Holdings, or LabCorp (LH) and Monogram Biosciences, Inc. (MGRM) announced that they have entered into a definitive agreement and plan of merger under which LabCorp will acquire all of the outstanding shares of Monogram in a cash tender offer for $4.55 per share.
By  trackseekingalpha   (-11.17%  risk: aggressive)  06/24/09 Comment


Unusual 11 Mid-Day Movers 6/23: MGRM, CGEN, GRH, RJET Higher; ACUR, HALO, PCBC, MTXX Lower
Monogram Biosciences, Inc. (NASDAQ: MGRM) <font>169% HIGHER;</font> Laboratory Corporation of America Holdings (NYSE: LH) and Monogram have entered into a definitive agreement and plan of merger under which LabCorp will acquire all of the outstanding shares of Monogram in a cash tender offer for $4.55 per share for an implied total equity value of approximately $106.7 million, or a total enterprise value of approximately $155 million at March 31, 2009, including net indebtedness.Compugen Ltd. (NASDAQ: CGEN) <font>45.5% HIGHER;</font> announced that CGEN-25007, a novel peptide antagonist of ...
By  Street Insider   (+9.67%  risk: moderate)  06/23/09 Comment


Investments in Healthcare - A Defensive Approach
Sl730001-3
49%


Stock RallyWe’ve had quite a spring rally in the last two months.  It’s hard to believe that the S&P 500 has rallied as much as 40% since the panic levels in March, and many individual issues have given investors chances to double or triple their money in just a few short weeks.  We are now beginning to hear whispers of economic recovery and new bull markets.  (Actually, by definition, this latest rally constitutes a bull market because it exceeds a 20% gain - but don’t try to explain that to investors who are still 41% below the October 2007 high).

<form>Other Articles of Interest
<><><> Obama’s Bu< /><><><>< /><><><>< /><><><><><><><><><><><><><><><><><><><><><><><><>< /><><><><><><><><><><><><>< /><><><><><><><><><><><>< /><><><><><><><><><><><><><>< /><><><>< /><><><>< /><>< /><><>< /><>< />< />...
By  Zachary Scheidt   (-6.77%  risk: moderate)  05/11/09 Comment


Trading FDA Decisions: 14 Extreme Trades
Mikerun
73%
Below is a summary of companies from the BioMedReports.com FDA Decision Date Calendar which have market caps below $200M, making them ideal candidates for extreme stock price volatility trades as their decision dates become imminent.

Dyax Corp. (DYAX) secured a narrow approval from a FDA Advisory Panel in early February (with a 6-5-2 vote) for its Kalbitor (ecallantide or DX-88) BLA with a PDUFA date of 3/23/09, which is designated for priority review in the treatment of acute attacks of hereditary angioedema (HAE is a rare disorder marked by severe swelling which can be fatal if the throat ...
By  Mike Havrilla   (+1.04%  risk: conservative)  03/11/09 Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.25% 381
2 Gerald Greene 18.14 +72.34% 210
3 stockmarketfunding.com 17.66 +25.65% 55
4 akiralegrand 13.47 +14.32% 61
5 anup2104 12.13 +76.91% 39


POPULAR STOCKS
Symbol Company Name Sentiment
MCD McDonald's Corp.
NVDA NVIDIA Corp
EBAY eBay Inc
MA MasterCard Inc
RIO Companhia Vale Do Rio Doce
GM General Motors Corp

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on LH

Visit streetinsider.com


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About Laboratory Corp. of America Holdings - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch